Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Von Hippel Lindau Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Testing effectiveness (Phase 2)Study completedNCT01967537
What this trial is testing

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsVon Hippel-Lindau SyndromeHippel-Lindau Disease
National Cancer Institute (NCI) 341
Testing effectiveness (Phase 2)Study completedNCT02859441
What this trial is testing

A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab

Who this might be right for
Von Hippel-Lindau Syndrome
National Eye Institute (NEI) 3
Testing effectiveness (Phase 2)Study completedNCT03907657
What this trial is testing

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau

Who this might be right for
Von-Hippel LindauKidney Disease, Chronic
UNC Lineberger Comprehensive Cancer Center 15
Not applicableEnrolling By InvitationNCT00102544
What this trial is testing

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Who this might be right for
AdenocarcinomaProstate NeoplasmsProstate Cancer+2 more
National Institutes of Health Clinical Center (CC) 3,894
Not applicableStudy completedNCT02120040
What this trial is testing

Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System

Who this might be right for
Hemangioblastoma (HB) of the Central Nervous System (CNS)
Assistance Publique Hopitaux De Marseille 42
Not applicableActive Not RecruitingNCT06195150
What this trial is testing

Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaVHL Syndrome
IRCCS San Raffaele 3
Not applicableUnknownNCT03979833
What this trial is testing

Drivers of Hypoxia-induced Angiogenesis in Tumor Development

Who this might be right for
Von Hippel-Lindau Disease
University of Copenhagen 10
Not applicableActive Not RecruitingNCT07275099
What this trial is testing

Quality of Life, Psychological Impact, and Care-related Challenges in Patients Affected by Von Hippel-Lindau Syndrome.

Who this might be right for
VHL - Von Hippel-Lindau Syndrome
IRCCS Ospedale San Raffaele 200
Testing effectiveness (Phase 2)Ended earlyNCT01266070
What this trial is testing

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00566995
What this trial is testing

Phase II Study of Vandetanib in Individuals With Kidney Cancer

Who this might be right for
Renal CancerVon Hippel Lindau
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00385333
What this trial is testing

Metabolic Mapping to Measure Retinal Metabolism

Who this might be right for
Macular DegenerationDiabetic RetinopathyHippel-Landau Disease+1 more
National Eye Institute (NEI) 28
Early research (Phase 1)Study completedNCT02108002
What this trial is testing

Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)

Who this might be right for
Von Hippel-Lindau Disease
National Institute of Neurological Disorders and Stroke (NINDS) 7
Not applicableLooking for participantsNCT05424016
What this trial is testing

Propranolol and Von Hippel-Lindau Disease

Who this might be right for
Hemangioblastoma of CNSVon Hippel-Lindau Disease
Assistance Publique - Hôpitaux de Paris 85
Early research (Phase 1)UnknownNCT05843305
What this trial is testing

BPI-452080 in Subjects With Solid Tumors

Who this might be right for
Solid TumorRenal Cell CarcinomaVon Hippel-Lindau Disease
Betta Pharmaceuticals Co., Ltd. 87
Not applicableUnknownNCT06391879
What this trial is testing

Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma

Who this might be right for
VHL SyndromeRenal Cell Carcinoma
Peking University First Hospital 300
Not applicableUnknownNCT05534854
What this trial is testing

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

Who this might be right for
Renal Tumor HistologyKidney CancerRenal Cell Carcinoma+11 more
RenJi Hospital 500
Large-scale testing (Phase 3)Looking for participantsNCT07405164
What this trial is testing

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

Who this might be right for
Von Hippel-Lindau DiseaseMalignant Neoplasms
Merck Sharp & Dohme LLC 450
Early research (Phase 1)Study completedNCT00056199
What this trial is testing

EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Hippel-Lindau Disease
National Eye Institute (NEI) 5
Large-scale testing (Phase 3)Study completedNCT01865747
What this trial is testing

Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 658
Next Page